+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Etanercept"

India Anti-rheumatic Drug Market Forecasts from 2023 to 2028 - Product Thumbnail Image

India Anti-rheumatic Drug Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 75 Pages
  • India
From
Brazil Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Brazil Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • September 2022
  • 76 Pages
  • Brazil
From
France Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

France Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • September 2022
  • 77 Pages
  • France
From
Germany Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Germany Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • September 2022
  • 75 Pages
  • Germany
From
From
Market Spotlight: Axial Spondyloarthritis (axSpA) - Product Thumbnail Image

Market Spotlight: Axial Spondyloarthritis (axSpA)

  • Report
  • March 2021
  • 52 Pages
  • Global
Market Spotlight: Psoriatic Arthritis - Product Thumbnail Image

Market Spotlight: Psoriatic Arthritis

  • Report
  • September 2020
  • 65 Pages
  • Global
From
From
Rheumatoid Arthritis Market and Forecast Analysis to 2025 - Product Thumbnail Image

Rheumatoid Arthritis Market and Forecast Analysis to 2025

  • Drug Pipelines
  • August 2018
  • 610 Pages
  • Global
From
Psoriatic Arthritis Market and Forecast Analysis 2035 - Product Thumbnail Image

Psoriatic Arthritis Market and Forecast Analysis 2035

  • Drug Pipelines
  • July 2018
  • 503 Pages
  • Global
From
Enbrel - Product Thumbnail Image

Enbrel

  • Report
  • May 2018
  • 61 Pages
  • Global
From
Loading Indicator

Etanercept is a biologic drug used to treat immune disorders such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It is a recombinant fusion protein that works by blocking the action of tumor necrosis factor (TNF), a protein involved in inflammation. Etanercept is administered by subcutaneous injection and is available in both brand name and generic forms. Etanercept is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other medications. It is generally well tolerated, with the most common side effects being injection site reactions, headache, and upper respiratory tract infections. The etanercept market is highly competitive, with several major players. These include Amgen, Pfizer, AbbVie, and Johnson & Johnson. Other companies in the market include Biogen, Merck, and Novartis. Show Less Read more